-transparent.png){kind=logo}
The HECA452 carbohydrate epitope, also termed cutaneous lymphocyte antigen, is known to bind to E-selectin and defines a human T cell subset preferentially found in inflamed skin. Activated T cells can express a functional form of the P-selectin glycoprotein ligand-1 (PSGL-1), the major ligand known for P-selectin. Here we show that PSGL-1 can exist in two forms, of which only one carries the HECA452 epitope and binds to E-selectin, while the other only binds to P-selectin. We have analyzed the glycoprotein ligands for E- and P-selectin on the mouse CD8+ T cell clone 4G3 at 4, 8, and 12 days after antigen-specific activation. Only at day 4 did the cells bind to E-selectin, whereas cells at all three activation stages bound to P-selectin. Expression of the HECA452 epitope correlated with E-selectin binding. In affinity isolation experiments, PSGL-1 was isolated as the major ligand by E-selectin-IgG and by P-selectin-IgG; however, PSGL-1 only bound to E-selectin at day 4, whereas it bound to P-selectin at all three activation stages. Immunoprecipitated PSGL-1 from cells at day 4, but not from cells at days 8 and 12, was recognized in immunoblots by monoclonal antibody HECA452. In immunoblots of total extracts of cells at day 4, HECA452 recognized a 240/140-kDa pair of protein bands as the major antigen. These bands could be completely removed by depletion of cell extracts with anti-PSGL-1 antibodies. Our data suggest that the carbohydrate requirements for binding of PSGL-1 to P-selectin differ from those necessary for binding to E-selectin. Furthermore, we conclude that the major glycoprotein carrier for the HECA452 epitope on activated 4G3 cells is PSGL-1.
E Borges, and
G Pendl, and
R Eytner, and
M Steegmaier, and
O Zöllner, and
D Vestweber
April 1997,
The Journal of cell biology,
E Borges, and
G Pendl, and
R Eytner, and
M Steegmaier, and
O Zöllner, and
D Vestweber
February 1996,
The Journal of biological chemistry,
E Borges, and
G Pendl, and
R Eytner, and
M Steegmaier, and
O Zöllner, and
D Vestweber
December 2000,
The Journal of experimental medicine,
E Borges, and
G Pendl, and
R Eytner, and
M Steegmaier, and
O Zöllner, and
D Vestweber
December 1998,
The Journal of biological chemistry,
E Borges, and
G Pendl, and
R Eytner, and
M Steegmaier, and
O Zöllner, and
D Vestweber
February 1997,
Blood,
E Borges, and
G Pendl, and
R Eytner, and
M Steegmaier, and
O Zöllner, and
D Vestweber
September 1995,
The Journal of biological chemistry,
E Borges, and
G Pendl, and
R Eytner, and
M Steegmaier, and
O Zöllner, and
D Vestweber
February 2007,
Journal of immunology (Baltimore, Md. : 1950),
E Borges, and
G Pendl, and
R Eytner, and
M Steegmaier, and
O Zöllner, and
D Vestweber
May 2017,
Current opinion in hematology,
E Borges, and
G Pendl, and
R Eytner, and
M Steegmaier, and
O Zöllner, and
D Vestweber
November 2000,
Blood,
E Borges, and
G Pendl, and
R Eytner, and
M Steegmaier, and
O Zöllner, and
D Vestweber
December 2009,
Journal of immunology (Baltimore, Md. : 1950),
